Studies on the molecular mechanism of thrombin receptor activation by means of ligand peptides containing a series of fluorinated phenylalanines

含氟苯丙氨酸系列配体肽激活凝血酶受体的分子机制研究

基本信息

  • 批准号:
    08458178
  • 负责人:
  • 金额:
    $ 4.03万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1997
  • 项目状态:
    已结题

项目摘要

The receptor of serine protease thrombin is a novel type of receptor, in which the peptite ligand is present in the N-terminal portion of the receptor itself. It was found that the receptor can be activated by the synthetic peptide Ser-Phe-Leu-Leu-Arg-Asn-Pro (SFLLRNP) without thrombin, and that Phe-2 of this peptide is crucially important to the receptor. recognition and activation. The aim of the present study is to clarify the interaction mode between Phe-2-phenyl and thrombin receptor aromatic groups. There are two possibilities for interaction of the ligand Phe-phenyl group : i.e., pi-pi stacking interaction and CH/pi interaction. To differentiate these interactions, we have incorporated a series of fluorinated phenylalanines. Fluorine is the most electronegative atom, the size of which is almost the same as hydrogen. It was immediately recognized that the fluorine substitution is allowed ony at the para-position. The derivative with pentafluorophenylalanine was totally devoid of … More activity. These results suggested that Phe-2 requires hydrogen atom(s) on the benzene ring presumably for interaction with the receptor. No activity enhancement observed for analogs with para-chloro-, bromo-, or iodophenylalanine indicated the importance of a high electronegativity of fluorine to intensify a dipole of CH(s) remaining in the Phe-2-benzenering, and suggested the presence of face-to-edge pi-pi interaction. Reduced but full activation by the derivative of 3,4,5-trifluorophenylalanine marked a hydrogen at position 6 as a structural element for direct interaction with the receptor aromatic ring. When strongly meta-orienting the trifluoromethyl group was introduced, only the derivative of 3-trifluoromethylpehnylalanine was fully active. All these results indicated that hydrogens at position 5 and 6 are the most important structural element for receptor interaction and that the interaction of Phe-2 of SFLLRNP appeared to be a face-to-edge pi-pi interaction based upon the CH/pi interaction between the Phe-2-phenyl group and the receptor aromatic group. Less
丝氨酸蛋白酶凝血酶受体是一种新型的受体,其中的多肽配体存在于受体本身的N端部分。研究发现,合成肽Ser-Phe-Leu-Leu-Arg-Asn-Pro(SFLLRNP)可以在没有凝血酶的情况下激活该受体,并且该肽的Phe-2对该受体至关重要。识别和激活。本研究的目的是阐明Phe-2-苯基与凝血酶受体芳香族基团的相互作用模式。配体Phe-苯基的相互作用有两种可能:即pi-pi堆积相互作用和CH/pi相互作用。为了区分这些相互作用,我们加入了一系列氟化苯丙氨酸。氟是电负性最强的原子,其大小几乎与氢相同。人们立即认识到,只允许在对位上进行氟取代。含五氟苯丙氨酸的衍生物完全不含…更多的活动。这些结果表明,Phe-2可能需要苯环上的氢原子(S)与受体相互作用。对氯丙氨酸、溴丙氨酸或碘苯丙氨酸的类似物没有观察到活性增强,这表明氟的高电负性对于加强保留在Phe-2-苯丙氨酸中的CH(S)的偶极是重要的,并表明存在面对面的pi-pi相互作用。被3,4,5-三氟苯丙氨酸的衍生物还原但完全激活,在第6位标记了一个氢,作为与受体芳香环直接相互作用的结构元素。当引入强间位取向的三氟甲基时,只有3-三氟甲基苯丙氨酸的衍生物具有完全的活性。所有这些结果表明,5和6位的氢是受体相互作用的最重要的结构元素,SFLLRNP的Phe-2相互作用似乎是基于Phe-2-苯基和受体芳香基之间的CH/pi相互作用的面到边的pi-pi相互作用。较少

项目成果

期刊论文数量(29)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Tsugumi Fujita: "A Moleular Design of Thrombin Receptor Ancagonist" Peptide Chemistry 1995. 261-264 (1996)
Tsugumi Fujita:“凝血酶受体拮抗剂的分子设计”肽化学 1995. 261-264 (1996)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tsugumi Fujita: "A Molecular Design of the Thrombin Receptor Antagonist" Peptide Chemistry 1995. 261-264 (1996)
Tsugumi Fujita:“凝血酶受体拮抗剂的分子设计”肽化学 1995. 261-264 (1996)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takeru Nose: "Functional Roles of Phenylalanine-2 of Thrombin Receptor-Tethered Ligand Peptide in Platelet Activation" Peptide Chemistry 1995. 265-268 (1996)
Takeru Nose:“凝血酶受体束缚配体肽的苯丙氨酸-2 在血小板激活中的功能”肽化学 1995. 265-268 (1996)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yasuyuki Shimohigashi: "π-π Interaction between Tethered-ligand Peptide and its Binding Site in Receptor Activation" Peptide Chemistry 1994. 369-372 (1995)
Yasuyuki Shimohigashi:“受体激活中系留配体肽与其结合位点之间的 π-π 相互作用” 肽化学 1994. 369-372 (1995)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yasuyuki Shimohigashi: "pi-pi Interaction between Tethered-ligand Peptide and its Binding Site in Receptor Activation" Peptide Chemistry 1994. 369-372 (1995)
Yasuyuki Shimohigashi:“受体激活中系留配体肽与其结合位点之间的 pi-pi 相互作用” 肽化学 1994. 369-372 (1995)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIMOHIGASHI Yasuyuki其他文献

SHIMOHIGASHI Yasuyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIMOHIGASHI Yasuyuki', 18)}}的其他基金

Nuclear receptor-mediated bisphenol endocrine disrupting signal toxicity
核受体介导的双酚内分泌干扰信号毒性
  • 批准号:
    15H01741
  • 财政年份:
    2015
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Invention of superagonists and superantagonists for ORL1 nociceptin receptor
ORL1伤害感受素受体的超级激动剂和超级拮抗剂的发明
  • 批准号:
    23657078
  • 财政年份:
    2011
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Signal toxicity mediated through nuclear receptors of new generation bisphenols
通过新一代双酚核受体介导的信号毒性
  • 批准号:
    22221005
  • 财政年份:
    2010
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Elucidation of bisphenol A low-dose effects mediated through the nuclear receptor ERRγ
阐明双酚 A 通过核受体 ERRγ 介导的低剂量效应
  • 批准号:
    19201012
  • 财政年份:
    2007
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Risk assessment of endocrine disruptors in nuclear receptors by means of antibody-sensing method to measure the conformation change associated with ligand binding
通过抗体传感方法测量与配体结合相关的构象变化,对核受体中的内分泌干扰物进行风险评估
  • 批准号:
    16310044
  • 财政年份:
    2004
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Novel Bioactive Conformation Constructed by Structurally Constrained CH/π Interaction between Amino Acids Side Chains
由氨基酸侧链之间结构约束的CH/π相互作用构建的新型生物活性构象
  • 批准号:
    10480152
  • 财政年份:
    1998
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Joint Study on Molecular Mechanism of Opioid Receptors
阿片受体分子机制联合研究
  • 批准号:
    09044230
  • 财政年份:
    1997
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).

相似海外基金

Diversity of haematopoietic cytokine receptor activation exploring with marine probes
用海洋探针探索造血细胞因子受体激活的多样性
  • 批准号:
    23K14019
  • 财政年份:
    2023
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Evolution of ligand-dependent Robo receptor activation mechanisms for axon guidance
合作研究:用于轴突引导的配体依赖性 Robo 受体激活机制的进化
  • 批准号:
    2247939
  • 财政年份:
    2023
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Standard Grant
Role of pregnane x receptor activation on macrophage function and diabetic wound healing
孕烷X受体激活对巨噬细胞功能和糖尿病伤口愈合的作用
  • 批准号:
    10730438
  • 财政年份:
    2023
  • 资助金额:
    $ 4.03万
  • 项目类别:
Significance of mineralocorticoid receptor activation in obesity-related kidney disease: Exploring urine biomarkers to reflect MR activation
盐皮质激素受体激活在肥胖相关肾脏疾病中的意义:探索反映 MR 激活的尿液生物标志物
  • 批准号:
    23K09671
  • 财政年份:
    2023
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of Nogo-B as a novel regulator of Toll-like receptor activation in virus-induced inflammation
鉴定 Nogo-B 作为病毒诱导炎症中 Toll 样受体激活的新型调节剂
  • 批准号:
    MR/X00922X/1
  • 财政年份:
    2023
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Research Grant
Role of Complement Receptor Activation in a Mixed Dementia Model
补体受体激活在混合痴呆模型中的作用
  • 批准号:
    10585080
  • 财政年份:
    2023
  • 资助金额:
    $ 4.03万
  • 项目类别:
Collaborative Research: Evolution of ligand-dependent Robo receptor activation mechanisms for axon guidance
合作研究:用于轴突引导的配体依赖性 Robo 受体激活机制的进化
  • 批准号:
    2247938
  • 财政年份:
    2023
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Standard Grant
Fine-tuning blood cell development: Using antibodies as surrogate cytokines to modify receptor activation and signalling in haematopoiesis
微调血细胞发育:使用抗体作为替代细胞因子来改变造血过程中的受体激活和信号传导
  • 批准号:
    2752707
  • 财政年份:
    2022
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Studentship
Polymer Approaches to Receptor Activation and Inhibition
受体激活和抑制的聚合物方法
  • 批准号:
    10795136
  • 财政年份:
    2022
  • 资助金额:
    $ 4.03万
  • 项目类别:
Development and validation of novel optical methods for direct screening of taste receptor activation
直接筛选味觉受体激活的新型光学方法的开发和验证
  • 批准号:
    10593556
  • 财政年份:
    2022
  • 资助金额:
    $ 4.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了